Cargando…

IA和HAD方案诱导治疗成人初诊急性髓系白血病的疗效比较

OBJECTIVE: To compare the efficacy of two induction regimens, namely, idarubicin combined with cytarabine(IA)versus the combination of homoharringtonine, daunorubicin, and cytarabine(HAD), in adult patients with newly diagnosed de novo acute myeloid leukemia(AML). METHODS: From May 2014 to November...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250960/
https://www.ncbi.nlm.nih.gov/pubmed/35680595
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.05.006